Chidzidzo chekiriniki chakagadzirirwa kuongorora kuchengetedzwa uye kushanda kweLNK01001 mune zvidzidzo zvine mwero kusvika kune zvakanyanya kushanda rheumatoid arthritis vane mhinduro isina kunaka kana kusashivirira kune yakajairwa yekugadzira chirwere-inogadzirisa antirheumatic zvinodhaka (csDMARDs).
LNK01001 ndiyo yekutanga mushonga wekuvandudza wakagadzirwa neLynk Pharmaceuticals, uye inosarudzika kinase inhibitor yekurapa zvirwere zve autoimmune. Kare, LNK01001 yakapedza zvidzidzo zvekiriniki zveChikamu I muzvidzidzo zvine hutano muzhizha regore rino muChina uye muAustralia neJapan, ichitsigirwa neLynk Pharmaceuticals nemumwe wayo wekuUS, zvichiteerana. Mhedzisiro yakaratidza kuti mushonga wakachengeteka uye wakatenderwa zvakanaka. Pamusoro pezvo, LNK01001 yakabvumidzwa neNational Medical Products Administration yeChina (NMPA) yekuongorora kwekiriniki kwezviratidzo zvitsva - ankylosing spondylitis (AS) uye atopic dermatitis (AD).
Muzvinafundo Xiaofeng Zeng ndiye mukuru anoongorora chidzidzo ichi uye mutungamiriri weDhipatimendi reRheumatology uye Immunology yePeking Union Medical College Hospital uye Chinese Academy yeMedical Sciences.
ZVOKUBVA MUNYAYA INO:
- Kare, LNK01001 yakapedza zvidzidzo zvekiriniki zveChikamu I muzvidzidzo zvine hutano muzhizha regore rino muChina uye muAustralia neJapan, zvichitsigirwa neLynk Pharmaceuticals nemumwe wayo wekuUS, zvichiteerana.
- Muzvinafundo Xiaofeng Zeng ndiye mukuru anoongorora chidzidzo ichi uye mutungamiriri weDhipatimendi reRheumatology uye Immunology yePeking Union Medical College Hospital uye Chinese Academy yeMedical Sciences.
- Chidzidzo chekiriniki chakagadzirirwa kuongorora kuchengetedzwa uye kushanda kweLNK01001 mune zvidzidzo zvine mwero kusvika kune zvakanyanya kushanda rheumatoid arthritis vane mhinduro isina kunaka kana kusashivirira kune yakajairwa yekugadzira chirwere-inogadzirisa antirheumatic zvinodhaka (csDMARDs).
